Microcap Adventrx Pharmaceuticals (ANX) shares plummet -56% after the FDA rejects a new application for the development-stage drug maker's lung-cancer treatment Exelbine. The agency says the authenticity of the drug products used in its pivotal bioequivalence trial could not be verified.
Microcap Adventrx Pharmaceuticals (ANX) shares plummet -56% after the FDA rejects a new...
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs